News | PACS | October 05, 2017

Infinitt Showcases Healthcare IT Solutions at RSNA 2017

Enterprise data management solutions help radiologists increase efficiency in data sharing and analysis

Infinitt Showcases Healthcare IT Solutions at RSNA 2017
 Infinitt-PACS-Enterprise-Search
Infinitt-Healthcare-Platform-IHP-enterprise-imaging-VNA

October 5, 2017 — Infinitt North America announced it will highlight several healthcare information technology (IT) offerings in its booth at the 2017 Annual Meeting of the Radiological Society of North America (RSNA 2017), Nov. 26-Dec. 1 in Chicago.

Infinitt PACS (picture archiving and communication system) includes:

  • Powerful analytics features, enabling radiologists to easily compare the current study with relevant studies while enhancing reading efficiency and diagnostic accuracy;
  • Intuitive labeling and tracking of lesion measurements;
  • Embedded multimodality image fusion;
  • Visual Timeline display of patient’s longitudinal study history; and
  • Dedicated worklists and folders for conference and education purposes.

Infinitt Healthcare Platform (IHP), an enterprise-level data management platform, increases efficiency in data management and sharing. The platform:

  • Provides a powerful vendor neutral archive (VNA) for DICOM and non-DICOM data;
  • Supports all standard interoperability protocols for seamless integration;
  • Configurable, rules-based Information Lifecycle Management (ILM); and
  • Works with Infinitt ULite and third-party universal viewers.

Infinitt’s Enterprise Search (ES) capability enables radiologists to:

  • Launch from Infinitt PACS or ULite zero footprint viewer;
  • Query for similar cases when reading to support the diagnostic process;
  • Access the PACS image study and the EMR (electronic medical record)/pathology report data related to the result;
  • Narrow search parameters by filtering according to ordering physician, report creator, patient age, patient gender, imaging modality, etc.;
  • Locate study data for research and teaching purposes;
  • Show supporting data as evidence of compliance with clinical decision support (CDS) requirements;
  • Save search results to a user folder, for ease of access later;
  • Easily export a selected portion or an entire search result to an Excel spreadsheet; and
  • Create tags (site/private) that can be searched using the advanced search option.

 

For more information: www.infinittna.com

Related Content

The impact of deploying artificial intelligence (AI) for radiation cancer therapy in a real-world clinical setting has been tested by Princess Margaret researchers in a unique study involving physicians and their patients.

Getty Images

News | Artificial Intelligence | June 15, 2021
June 15, 2021 — The impact of deploying ...
Cina Chest is part of Avicenna’s CINA family of AI tools that support the treatment of emergencies, including CINA HEAD, its FDA-cleared and CE-Marked solution that supports the detection and triage of stroke and neurovascular emergencies.
News | Artificial Intelligence | June 03, 2021
June 3, 2021 — Medical imaging AI specialist Avicenna.AI announced
International medical imaging IT and cybersecurity company Sectra will install its solution for digital pathology at Institut Curie, one of the most recognized and prestigious cancer centers in France.
News | Enterprise Imaging | May 24, 2021
May 24, 2021 — International medical imaging IT and cybersecurity company ...
The Healthcare Information and Management Systems Society, Inc. (HIMSS) 2021 Conference, scheduled for August 9-13 in Las Vegas, will be one of the first to take a step back to normalcy

Getty Images

News | HIMSS | May 17, 2021
May 17, 2021 — It looks like in-person conferences are making a comeback.
Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address

Artificial intelligence (AI)-driven healthcare has potential to transform medical decision-making and treatment, but AI algorithms must be thoroughly tested and continuously monitored to avoid unintended consequences to patients. In JAMA Network Open, Regenstrief Institute President Peter Embí, M.D., calls for algorithmovigilance (a term he coined for scientific methods and activities relating to evaluation, monitoring, understanding and prevention of adverse effects of algorithms in healthcare) to address inherent biases in healthcare algorithms and their deployment. Image courtesy of Regenstrief Institute

News | Artificial Intelligence | May 14, 2021
May 14, 2021 — Artificial intelligence